Part of:

How can the government successfully engage the private sector in health for equitable distribution of COVID-19 vaccines? An interview series.


As the world navigates the recovery phase of the COVID-19 pandemic, we are witnessing how access to COVID-19 vaccines is deeply inequitable at the country, regional and global level, often owing to differences in wealth concentrations within and across the three levels. The private sector plays a key role in health systems, particularly in low- and middle-income countries and has contributed in various capacities to vaccine procurement and distribution efforts.  

Opinion pieces provided by prominent thinkers in the space can help share different perspectives on how the private sector can effectively and ethically participate in equitable distribution of COVID-19 vaccines. In this Op-Ed series, we share perspectives of stakeholders from various backgrounds including academia, multi-lateral organizations, commercial organizations and governments  

Opinion Piece - Alicia Ely Yamin, Harvard TH Chan School of Public Health

Opinion Piece - Michael Griffin, WHO


Pour ajouter des commentaires, prière de signer ou de se logger